John F. Gaither Jr.

John F. Gaither Jr. is a declared insider of Talecris Biotherapeutics Holdings Corp., with filings sourced from SEC (Form 4). Over a trading history stretching from 30 September 2009 to 1 June 2011, the count stands at 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 3 June 2011 with a transaction in Talecris Biotherapeutics Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.